Elekta reported better-than-expected Q4 results – a second consecutive quarterly beat, driven by an easing supply chain which resulted in better order book conversion. Solutions continued to grow at a faster pace vs. Service. More importantly, the firm reported an improvement in operating profitability, backed by cost reduction initiatives. Overall, Elekta remains an attractive MedTech story, underpinned by promising market dynamics, easing supply chain challenges and innovation prowess; our pos ....
